Oncology Institute Inc expected to post a loss of 13 cents a share - Earnings Preview

Oncology Institute

11/08/2025 22:05

Oncology Institute Inc TOI.OQ TOI.O is expected to  show a rise in quarterly revenue when it reports  results on August 13 for the period ending June 30 2025

The Cerritos California-based  company is expected to report a 16.3% increase in revenue to $114.6 million from $98.58 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Oncology Institute Inc is for a loss of 13 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The average consensus recommendation for the healthcare facilities & services peer group is also "Buy".​

Wall Street's median 12-month price target for Oncology Institute Inc is $7.00, about 38.9% above its last closing price of $4.28

This summary was machine generated August 11 at 21:05 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)